Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

A Prospective Observational Study of Neutropenia and Anemia Management in Subjects With Solid Tumors Receiving Myelotoxic Chemotherapy

NCT00883181 is registered in ClinicalTrials.gov with Amgen as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00883181 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
A Prospective Observational Study of Neutropenia and Anemia Management in Subjects With Solid Tumors Receiving Myelotoxic Chemotherapy
Lead sponsor
Amgen
Phase
Observational
Overall status
Completed
Start date
November 30, 2006
Completion date
September 30, 2014
Enrollment
1,370 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

breast cancer, non-small cell lung cancer, ovarian cancer, small cell lung cancer